Amoy Diagnostics Co Ltd (300685) — Capital Reinvestment Ratio
Latest as of September 2025:
0.23x
Amoy Diagnostics Co Ltd (300685) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥110.87 Million) in capital expenditures (CN¥25.34 Million). See 300685 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.23x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥110.87 Million
CNY
Capital Expenditures
CN¥25.34 Million
CNY
Data as of
Sep 2025
Most recent filing
Amoy Diagnostics Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Amoy Diagnostics Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Amoy Diagnostics Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Amoy Diagnostics Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see Amoy Diagnostics Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | CN¥341.85 Million | CN¥40.21 Million | ▼ -21.7% |
| 2023 | 0.15x | CN¥298.72 Million | CN¥44.87 Million | ▼ -71.4% |
| 2022 | 0.53x | CN¥149.04 Million | CN¥78.29 Million | ▲ +18.5% |
| 2021 | 0.44x | CN¥168.16 Million | CN¥74.55 Million | ▲ +69.0% |
| 2020 | 0.26x | CN¥220.69 Million | CN¥57.89 Million | ▲ +70.5% |
| 2019 | 0.15x | CN¥151.52 Million | CN¥23.31 Million | ▼ -63.1% |
| 2018 | 0.42x | CN¥93.45 Million | CN¥38.97 Million | ▲ +76.8% |
| 2017 | 0.24x | CN¥91.89 Million | CN¥21.68 Million | ▼ -83.3% |
| 2016 | 1.42x | CN¥32.18 Million | CN¥45.60 Million | ▼ -9.2% |
| 2015 | 1.56x | CN¥19.10 Million | CN¥29.79 Million | ▼ -47.0% |
| 2014 | 2.94x | CN¥15.69 Million | CN¥46.20 Million | ▼ -25.6% |
| 2013 | 3.96x | CN¥8.56 Million | CN¥33.88 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow